Clinical Trials in Nashville

Showing 18001-18020 of 20,298 trials

Study of TRM-1 (TRAIL-R1 Monoclonal Antibody) in Subjects With Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)

NCT00094848

The purpose of this study is to evaluate the safety, efficacy and exposure to TRM-1 in subjects with relapsed or refractory Non-Hodgkin's Lymphoma (NHL).

Lymphoma, Non-Hodgkin

Human Genome Sciences Inc.Started Jun 2004

Rochester, Minnesota, United States • Omaha, Nebraska, United States • Buffalo, New York, United States +4 more locations

COMPLETEDPhase 2< 1 mile

Study of TRM-1(TRAIL-R1 Monoclonal Antibody) in Subjects With Relapsed or Refractory Non-Small Cell Lung Cancer (NSCLC)

NCT00092924

The purpose of this study is to evaluate the efficacy and safety of TRM-1 in subjects with relapsed or refractory non-small cell lung cancer.

Carcinoma, Non-Small-Cell Lung

Human Genome Sciences Inc.

Denver, Colorado, United States • Chicago, Illinois, United States • Durham, North Carolina, United States +2 more locations

COMPLETEDPhase 2< 1 mile

3-AP and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic Cancer

NCT00064051

RATIONALE: Drugs used in chemotherapy such as gemcitabine use different ways to stop tumor cells from dividing so they stop growing or die. 3-AP may stop the growth of tumor cells by blocking the enzymes necessary for tumor cell growth and may help gemcitabine kill more cancer cells by making them more sensitive to the drug. PURPOSE: This phase II trial is studying how well giving gemcitabine together with 3-AP works in treating patients with unresectable or metastatic pancreatic cancer.

Pancreatic Cancer

Vion PharmaceuticalsStarted Jan 2003

Chicago, Illinois, United States • Indianapolis, Indiana, United States • Minneapolis, Minnesota, United States +4 more locations

Study of TRM-1 (TRAIL-R1 Monoclonal Antibody) in Subjects With Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)

Study of TRM-1(TRAIL-R1 Monoclonal Antibody) in Subjects With Relapsed or Refractory Non-Small Cell Lung Cancer (NSCLC)

3-AP and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic Cancer

Find Trials by Condition in Nashville

Case-Control Viramune (Nevirapine) Toxicogenomics Study

Open Label Extension Study of STX209 (Arbaclofen) in Autism Spectrum Disorders

Biomarker Testing and DNA Collection in Subjects Participating in Protocol 22001

Doxorubicin HCI Liposome Injection Versus Weekly Docetaxel in Patients First Relapse Metastatic Breast Cancer

Late-life Depression and Cerebral Perfusion

An Open Label Extension Study in Subjects With Fragile X Syndrome

Balloon REmodeling Antrostomy THErapy Study

Trial Of IW001 in Patients With Idiopathic Pulmonary Fibrosis

Bevacizumab (Avastin) and RAD001(Everolimus)in the Treatment of Advanced Clear Cell Renal Carcinoma

Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus

A Study to Evaluate Bleeding Patterns With Three Different Doses of DR-1031 Compared to Seasonale

Mycophenolate Mofetil Immunosuppression Without/With Reduced Dose Calcineurin Inhibitor Long After Liver Transplantation

A Study of the Safety and Efficacy of Infliximab(REMICADE ) in Pediatric Patients With Moderately to SeverelyActive Ulcerative Colitis

Allogeneic Stem Cell Transplantation Following Chemotherapy in Patients With Hemoglobinopathies

Rapid Assessment of Bedside BNP In Treatment of Heart Failure (RABBIT)

A Study to Evaluate High Protein Supplementation in HIV-Positive Patients With Stable Weight Loss

Effect of Anti-HIV Therapy (HAART) on HIV Levels in the Lungs and on Lung Cell Inflammation in HIV-Infected Patients